Company news

Novamind Inc news in 2021

Novamind Inc's news releases, calls and decks from 2021, newest first.

View company

Novamind Signs Definitive Agreement to Acquire Arizona-based Clinics

December 23, 2021

Novamind Opens New Clinic with Specialized Focus on Substance Use Disorders

December 6, 2021

Novamind to Present at the H.C. Wainwright 2nd Annual Psychedelics Conference on December 6

December 2, 2021

Novamind Partners with Uruguay-Based Bienstar Wellness to Develop Latin America's First Integrative Mental Health Clinic Network

December 1, 2021

Novamind Reports Fiscal Q1 Financial Results and Operating Highlights

November 29, 2021

Novamind Unveils New Logo and Invests in Unified Brand

November 24, 2021

Novamind Signs LOI to Acquire Two Mental Health Clinics in Arizona

November 16, 2021

Novamind to Present at International Summit on Psychedelic Therapies for Mental Illness

November 15, 2021

Novamind Enters New Lease Agreement Responding to Patient Demand

November 12, 2021

Novamind Secures Insurance Coverage for Ketamine from Four Major Payors

November 10, 2021

Novamind Announces Revocation of Cease Trade Order and Reinstatement of Trading

November 8, 2021

CSE Bulletin: Reinstatement - Novamind Inc. (NM)

November 8, 2021

Novamind Reports FY2021 Financial Results and Operating Highlights

November 5, 2021

CSE Bulletin: Suspensions (MMI, CNFA, VPN, NM, EXM)

November 4, 2021

Novamind Announces Cease Trade Order and Delay in Filing Annual Financial Statements

November 4, 2021

Novamind Unveils Stealth Mode Investment in Alto Neuroscience

October 22, 2021

Novamind Granted DEA Licenses for Psilocybin Research

October 13, 2021

Novamind to Present at LD Micro and KCSA Conferences

October 8, 2021

Novamind Launches New Psychedelic Palliative Care Program

October 7, 2021

Novamind to Deliver Keynote at PSYCH Investor Summit on October 7, 2021

October 4, 2021

Novamind Opens 6th Integrative Psychiatry Clinic, Adds 3rd Clinical Research Site

September 30, 2021

Novamind to Present at Benzinga Healthcare Conference

September 29, 2021

Novamind Announces DTC Eligibility for its Common Shares

September 24, 2021

Novamind to Present at Benzinga Healthcare Conference

September 23, 2021

Novamind Announces Inclusion in NYSE Listed AdvisorShares Psychedelics ETF

September 20, 2021

Novamind to Present at Life Sciences Investor Forum

September 14, 2021

Novamind to Serve as Research Site for Karuna Therapeutics Late-Stage Clinical Trial

September 13, 2021

Novamind Uplists to OTCQB Venture Market

September 9, 2021

Novamind to Present at H.C. Wainwright 23rd Annual Global Investment Conference

September 8, 2021

Novamind Divests Non-Core Retreat Investment

August 11, 2021

Novamind Strengthens Mental Health Expertise, Adds Communications Leader

August 6, 2021

Novamind Opens 5th Clinic Location Specialized in Integrative Psychiatry for Patients with Treatment-Resistant Conditions

July 29, 2021

Novamind Has Applied to Have its Common Shares Posted for Trading on the OTCQB in the United States

July 21, 2021

Novamind Selected as Research Site for Bionomics' PTSD Clinical Trial

July 8, 2021

Novamind Launches Psychedelic Therapy Frontiers Podcast

June 30, 2021

Novamind Welcomes Dr. Paul Thielking as Chief Scientific Officer

June 23, 2021

Novamind Announces US$1,000,000 Strategic Investment in Stealth Mode Drug Development Company

June 17, 2021

Novamind to Present at the H.C. Wainwright Psychedelics Conference on June 17, 2021

June 15, 2021

Novamind Launches Psychedelic Therapy Protocol for Frontline Healthcare Workers

June 10, 2021

Novamind Reports Fiscal Q3 Financial Results and Operating Highlights

June 1, 2021

Novamind Opens Client Care Center to Support High Demand for Treatments

May 18, 2021

Novamind Doubles in Size, Adds Four New Psychedelic Mental Health Clinics

May 4, 2021

Novamind Collaborates with Center for Change

April 21, 2021

Novamind Announces Participation at the Planet MicroCap Showcase on April 20 - 22, 2021

April 20, 2021

Novamind to Present at the Planet MicroCap Virtual Event on April 22, 2021

April 19, 2021

Novamind Increases Strategic Investment in Bionomics

April 13, 2021

Novamind to Present at Benzinga Biotech Conference

March 24, 2021

Novamind to Present at Benzinga Biotech Conference

March 22, 2021

Novamind Partners with Merck for New Treatment-Resistant Depression Trial

March 18, 2021

Novamind Expands Leadership Team, Accelerating M&A

March 3, 2021

Older news releases →

Decks in 2021